Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Modulates the O-glycosylation and complex N- glycosylation steps occurring during the Golgi maturation of several proteins such as APP, BACE1, SEAP or PRNP. Additionally we are shipping TMEM59 Proteins (8) and many more products for this protein.
Showing 10 out of 28 products:
Human Polyclonal TMEM59 Primary Antibody for IHC, IHC (p) - ABIN442274
Bakulski, Dolinoy, Sartor, Paulson, Konen, Lieberman, Albin, Hu, Rozek: Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. in Journal of Alzheimer's disease : JAD 2012
The TMEM59 gene identified from our discovery approach was recently implicated in amyloid-beta protein precursor post-translational processing, supporting a role for epigenetic change in LOAD pathology.
TMEM59 affects amyloid precursor protein (show APP Antibodies) shedding by reducing its acccess to cellular components.
MicroRNA-351 regulates TMEM 59 (DCF1) expression and mediates neural stem cell morphogenesis.
The expression of tmem59 is an important factor contributing to Alzheimer's disease.
Chromosome mapping of 3 proteins (CRSP9 (show MED7 Antibodies), ETF1 (show ETF1 Antibodies) and TMEM59) in swine
Modulates the O-glycosylation and complex N- glycosylation steps occurring during the Golgi maturation of several proteins such as APP, BACE1, SEAP or PRNP. Inhibits APP transport to the cell surface and further shedding (By similarity).
transmembrane protein 59
, liver membrane-bound protein
, thymic dendritic cell-derived factor 1